Spinal Mobility, Axial Rigidity, and Kinesiophobia in PD Patients With and Without TMD
This observational study aims to measure spinal mobility in individuals with Parkinson's disease, both with and without Temporomandibular Disorders (TMD), using tests such as the Modified-Modified Schober Test, Tragus-to-Wall Distance, Occiput-to-Wall Distance, and Intermalleolar Distance.
Data Collection
Collected at a single point in time - Cross-sectionalSynucleinopathies+20
+ Basal Ganglia Diseases
+ Brain Diseases
Other
Utilizing specific methods not covered by standard models in order to address unique research questions.Summary
Study start date: September 23, 2026
Actual date on which the first participant was enrolled.This study focuses on individuals with Parkinson's disease (PD) and explores the connection between their spinal mobility, axial rigidity (stiffness in the midsection of the body), and a condition called Temporomandibular Disorders (TMD), which affects the jaw joint. The goal is to understand if there are differences in spinal mobility, axial rigidity, and fear of movement (kinesiophobia) between PD patients with and without TMD. The study also aims to investigate if there's a biomechanical link between TMD and these aspects in PD patients. The study takes place at the Neurology Outpatient Clinic of Hatay Mustafa Kemal University Research and Training Hospital. Participants, aged 40-75, diagnosed with PD, and meeting specific criteria will undergo a single session of evaluations. These include assessing the presence of TMD, measuring jaw range of motion, spinal mobility, axial rigidity, posture, and kinesiophobia. Various tests and measurements will be used, such as the Fonseca Anamnestic Index, the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS), and the Tampa Scale for Kinesiophobia. The results are expected to provide insights into how spinal mobility, axial rigidity, and kinesiophobia might impact the temporomandibular system in PD, potentially guiding assessment and rehabilitation strategies.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.60 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 35 to 75 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Hatay Mustafa Kemal Universty
Hatay, Turkey (Türkiye)Open Hatay Mustafa Kemal Universty in Google Maps